Page 215 - Tata_Chemicals_yearly-reports-2020-2021
P. 215

Integrated Report   Statutory Reports  Financial Statements
              1-59                60-146             Standalone


            44  Commitments
                                                                                                       ` in crore
                                                                                             As at        As at
                                                                                     March 31, 2021 March 31, 2020
                 Estimated amount of contracts remaining to be executed on capital account and not provided
                 for                                                                        383.96       289.57
                 Commitment towards partly paid investment                                      -          9.19

            45.  Contingent liabilities and assets
            45.1 Contingent liabilities
            (a)   Claims not acknowledged by the Company relating to the cases contested by the Company and which, in the opinion of the
                Management, are not likely to devolve on the Company relating to the following areas:
                                                                                                       ` in crore
                                                                                             As at        As at
                                                                                     March 31, 2021 March 31, 2020
                 (i)    Excise, Customs and Service Tax @                                   104.32        86.41
                 (ii)   Sales Tax @                                                          37.92        43.89
                 (iii)  Labour and other claims against the Company not acknowledged as debt  26.11       24.60
                 (iv)  Income Tax
                     (pending before Appellate authorities in respect of which the Company is in appeal) **  529.81  551.39
                 (v)   Income Tax
                      (decided in Company's favor by Appellate authorities and Department is in further appeal)  15.54  15.54
                 (vi)  Contractual obligation upto                                           34.75        34.75
                Item (vi)) above includes ` 34.75 crore (2020: ` 34.75 crore) relating to discontinued operations.

            (b)   Guarantees provided by the Company to third parties on behalf of subsidiaries aggregates USD 91.8 million & GBP 105.6 million
                (` 1,735.10 crore) (2020: USD 111.60 million & GBP 2.76 million (` 870.19 crore)).

                 **The Company has on-going disputes with income tax authorities mainly pertaining to disallowance of expenses and the
                computation  of,  or  eligibility  of  the  Company’s  availment  of  certain  tax  incentives  or  allowances.  Most  of  these  disputes  and/
                or disallowances are repetitive in nature spanning across multiple years. All the  Tax demands are being contested by the
                company.
                @ Excise Duty cases include disputes pertaining to reversal of input tax credit on common input, refund of duty paid under protest.
                Custom Duty cases include disputes pertaining to import of capital equipment against scripts, tariff classification issues, denial
                of FTA benefit. VAT/CST/Entry Tax cases include disputes pertaining to Way Bill, reversal/disallowance of input tax credit, pending
                declaration forms. All the Tax demands are being contested by the company.

                 It is not practicable for the Company to estimate the timings of cash outflows, if any, in respect of the above pending resolution of
                the respective proceedings as it is determinable only on receipt of judgments / decisions pending with various forums/authorities.
                 The company has reviewed all its pending litigations and proceedings and has adequately provided for where provisions are required
                and disclosed as contingent liabilities where applicable, in the Standalone Financial Statements.













                                                                                                           213
   210   211   212   213   214   215   216   217   218   219   220